new cancer drug, Gleevec

June 2001

There's a lot of excitement about the new cancer drug, Gleevec.

The excitment is because Gleevec is effective for treating chronic myeloid leukemia (CML)...plus it might also be useful for other forms of cancer.

Gleevec (imatinib) is one of the first of several designer drugs that specifically target cancer cells.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote